Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial β-carbon-sulfur lyase (β-CSL) enzymes represent a family of microbial enzymes responsible for cleaving β-carbon–sulfur bonds in sulfur-containing amino acids and their conjugates, such as L-cysteine and L-methionine, to generate volatile sulfur compounds (VSCs) including hydrogen sulfide, methyl mercaptan, and dimethyl sulfide[1][4][5]. Major gene-encoded forms include methionine γ-lyase (mdeA), cystathionine γ-lyase, and homocysteine desulfhydrase (mccB)[1][2][4]. These enzymes play a central role in oral malodor (halitosis), are key virulence factors for periodontopathogenic bacteria (e.g., Fusobacterium nucleatum, Porphyromonas gingivalis, Treponema denticola), and can modulate the composition and function of the oral microbiota[5][6]. Production of VSCs by these enzymes is directly linked to the breakdown of proteinaceous substrates and is regulated by factors like the presence of pyridoxal phosphate as a cofactor[1]. Enzyme activity and gene expression can be potential therapeutic targets or diagnostic biomarkers for oral and extra-oral diseases associated with the microbiome[4][5][6].
Enzyme inhibition leading to decreased VSC production and reduction of halitosis Targeting oral microbiome composition to suppress VSC-producing bacteria Potential use of PLP (pyridoxal phosphate) antagonists to block enzyme cofactors
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial β-carbon-sulfur lyase (β-CSL).